Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBurning Rock Biotech Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$15.75 | -$15.75 | -$15.75 |
| Q2 2026 | 1 | -$15.87 | -$15.87 | -$15.87 |
| Q3 2026 | 1 | -$17.18 | -$17.18 | -$17.18 |
| Q4 2026 | 1 | -$16.25 | -$16.25 | -$16.25 |
| Q1 2027 | 1 | -$19.42 | -$19.42 | -$19.42 |
| Q2 2027 | 1 | -$19.00 | -$19.00 | -$19.00 |
| Q3 2027 | 1 | -$18.18 | -$18.18 | -$18.18 |
| Q4 2027 | 1 | -$22.49 | -$22.49 | -$22.49 |
| Q1 2028 | 1 | -$13.93 | -$13.93 | -$13.93 |
| Q2 2028 | 1 | -$13.00 | -$13.00 | -$13.00 |
| Q3 2028 | 1 | -$12.44 | -$12.44 | -$12.44 |
| Q4 2028 | 1 | -$12.51 | -$12.51 | -$12.51 |
| Q1 2029 | 1 | -$10.48 | -$10.48 | -$10.48 |
| Q2 2029 | 1 | -$10.22 | -$10.22 | -$10.22 |
| Q3 2029 | 1 | -$9.71 | -$9.71 | -$9.71 |
| Q4 2029 | 1 | -$9.61 | -$9.61 | -$9.61 |
Burning Rock Biotech Ltd Earnings Date And Information
Burning Rock Biotech Ltd last posted its earnings results on Thursday, March 12th, 2026. The company reported $-0.21 earnings per share for the quarter, topping analysts' consensus estimates of $-1.39699 by $1.18699. The company had revenue of 124.57 M for the quarter and had revenue of 524.87 M for the year. Burning Rock Biotech Ltd has generated $-50 earnings per share over the last year ($-49.6 diluted earnings per share) and currently has a price-to-earnings ratio of -2.16. Burning Rock Biotech Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Burning Rock Biotech Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/28/2026 | Q4 2025 | N/A | -$14.70 | N/A | N/A | $124.57 M |
| 11/20/2025 | Q3 2025 | N/A | -$15.60 | N/A | $131.62 M | $131.62 M |
| 09/08/2025 | Q2 2025 | N/A | -$9.00 | N/A | N/A | $148.55 M |
| 06/06/2025 | Q1 2025 | N/A | -$12.50 | N/A | N/A | $133.08 M |
| 04/29/2025 | Q4 2024 | N/A | -$78.70 | N/A | N/A | $126.02 M |
| 12/04/2024 | Q3 2024 | N/A | -$34.60 | N/A | N/A | $128.64 M |
| 08/23/2024 | Q2 2024 | N/A | -$105.30 | N/A | N/A | $135.53 M |
| 05/29/2024 | Q1 2024 | -$1.52 | -$118.50 | -116.98 | N/A | $125.62 M |
| 04/29/2024 | Q4 2023 | N/A | -$158.40 | N/A | N/A | $121.09 M |
| 11/30/2023 | Q3 2023 | -$1.81 | -$171.00 | -169.19 | N/A | $127.57 M |
| 06/30/2023 | Q2 2023 | N/A | -$128.10 | N/A | N/A | $146.27 M |
| 05/30/2023 | Q1 2023 | -$2.00 | -$180.90 | -178.9 | N/A | $142.52 M |
| 12/31/2022 | Q4 2022 | N/A | -$211.20 | N/A | N/A | $142.24 M |
| 11/16/2022 | Q3 2022 | N/A | -$222.80 | N/A | N/A | $154.63 M |
| 08/31/2022 | Q2 2022 | -$3.60 | -$250.00 | -246.4 | N/A | $130.85 M |
| 05/31/2022 | Q1 2022 | -$2.30 | -$250.10 | -247.8 | N/A | $135.52 M |
| 12/31/2021 | Q4 2021 | N/A | -$240.40 | N/A | N/A | $147.35 M |
| 11/16/2021 | Q3 2021 | N/A | -$163.60 | N/A | N/A | $126.62 M |
| 06/30/2021 | Q2 2021 | N/A | -$195.70 | N/A | N/A | $127.28 M |
| 05/25/2021 | Q1 2021 | -$1.40 | -$164.70 | -163.3 | N/A | $106.62 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Burning Rock Biotech Ltd Earnings: FAQ's
In the previous quarter, Burning Rock Biotech Ltd (:BNR) reported $-0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.39699 by $1.18699.
The conference call for Burning Rock Biotech Ltd's latest earnings report can be listened to online.
The conference call transcript for Burning Rock Biotech Ltd's latest earnings report can be read online.
Burning Rock Biotech Ltd (:BNR) has a recorded annual revenue of $524.87 M.
Burning Rock Biotech Ltd (:BNR) has a recorded net income of $-53,838,104.Burning Rock Biotech Ltd has generated $-49.6 earnings per share over the last four quarters.
Burning Rock Biotech Ltd (:BNR) has a price-to-earnings ratio of -2.16 and price/earnings-to-growth ratio is -0.01.